EFFECT OF GUSELKUMAB ADMINISTERED EVERY 8 WEEKS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS PERSISTS BETWEEN CONSECUTIVE DOSES AND IS DURABLE: POST HOC ANALYSIS OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED STUDY

被引：0

作者：

Mease, P. J. ^{[1
,2
]}

Baraliakos, X. ^{[3
]}

Chandran, V. ^{[4
,5
]}

Soriano, E. ^{[6
]}

Nash, P. ^{[7
,8
]}

Deodhar, A. ^{[9
]}

Rampakakis, E. ^{[10
,11
]}

Shiff, N. ^{[12
,13
]}

Chakravarty, S. D. ^{[14
,15
]}

Shawi, M. ^{[16
]}

Merola, J. F. ^{[17
,18
]}

Mcinnes, I. ^{[19
]}

机构：

[1] Providence St Joseph Hlth, Swedish Med Ctr, Seattle, WA USA

[2] Univ Washington, Rheumatol Res, Seattle, WA 98195 USA

[3] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet, Claudiusstr, Germany

[4] Univ Toronto, Toronto, ON, Canada

[5] Schroeder Arthrit Inst, Dept Med, Div Rheumatol, Toronto, ON, Canada

[6] Hosp Italiano Buenos Aires, Rheumatol, Buenos Aires, DF, Argentina

[7] Griffith Univ, Maroochydore, Australia

[8] Univ Queensland, Rheumatol Res Unit, Maroochydore, Australia

[9] Oregon Hlth & Sci Univ, Div Arthrit & Rheumat Dis, Portand, OR USA

[10] McGill Univ, Dept Pediat, Montreal, PQ, Canada

[11] JSS Med Res Inc, Sci Affairs, Montreal, PQ, Canada

[12] Janssen Sci Affairs LLC, Immunol, Horsham, PA USA

[13] Univ Saskatchewan, Community Hlth & Epidemiol, Saskatoon, SK, Canada

[14] Janssen Sci Affairs LLC, Immunol, Horsham, PA USA

[15] Drexel Univ, Coll Med, Div Rheumatol, Philadelphia, PA 19104 USA

[16] Janssen Pharmaceut Co Johnson & Johnson, Immunol Global Med Affairs, Horsham, PA USA

[17] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA

[18] Harvard Med Sch, Div Rheumatol & Immunol, Boston, MA 02115 USA

[19] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷

关键词：

Clinical trials; Psoriatic arthritis; Outcome measures;

D O I：

10.1136/annrheumdis-2023-eular.642

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

AB1108

引用

页码：1782 / 1783

页数：2

共 50 条

[21] Stringent Disease Activity Control at 2 Years Across Psoriatic Arthritis Domains Irrespective of Baseline Characteristics in Patients Treated with Guselkumab: Post-Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study
Ritchlin, Christopher T.
Mease, Philip J.
Boehncke, Wolf-Henning
Tesser, John
Chakravarty, Soumya D.
Rampakakis, Emmanouil
Shawi, May
Merola, Joseph F.
McInnes, Iain B.
Deodhar, Atul
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB225 - AB225
[22] Ixekizumab Efficacy in Patients with Severe Peripheral Psoriatic Arthritis: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (SPIRIT-P1)
Kameda, Hideto
Hagimori, Kohei
Morisaki, Yoji
Holzkaemper, Thorsten
Konomi, Ayako
Dobashi, Hiroaki
RHEUMATOLOGY AND THERAPY, 2023, 10 (06) : 1683 - 1703
[23] Ixekizumab Efficacy in Patients with Severe Peripheral Psoriatic Arthritis: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (SPIRIT-P1)
Hideto Kameda
Kohei Hagimori
Yoji Morisaki
Thorsten Holzkämper
Ayako Konomi
Hiroaki Dobashi
Rheumatology and Therapy, 2023, 10 : 1683 - 1703
[24] Vunakizumab in Patients with Active Psoriatic Arthritis: A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study
Zou, Hejian
Wan, Weiguo
Xue, Yu
Sun, Lingyun
Zhang, Ning
Chen, Haiying
Shi, Xiaofei
Liu, Shengyun
Chen, Lin
Ma, Xinmei
Wei, Hua
Jiang, Zhenyu
Li, Xiaomei
Fan, Hongtao
Li, Hongbin
Li, Jingyang
Wu, Rui
Shi, Guixiu
Zhu, Jing
Kong, Xiaodan
Lu, Yuewu
Cui, Xiaojing
Zheng, Qianning
Bai, Xiaoyan
Dong, Guangchao
ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 5240 - 5242
[25] Efficacy of ixekizumab in patients with psoriatic arthritis: Results of a phase 3 randomized, double-blind, active- and placebo-controlled study
Mease, Philip
van der Heijde, Desiree
Ritchlin, Christopher
Cuchacovich, Rachel
Shuler, Catherine
Lin, Chen-Yen
Vangerow, Harald
Samanta, Suvajit
Lee, Chin
Gladman, Dafna
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB248 - AB248
[26] Post-inflammatory and Degenerative Changes in Patients with Psoriatic Arthritis and Axial Manifestations: Post-hoc Analysis from a Double-blind, Randomized, Phase 3b Trial
Baraliakos, Xenofon
Pournara, Effie
Coates, Laura
Navarro-Compan, Victoria
White, Roisin
Schulz, Barbara
Landewe, Robert
ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 4071 - 4073
[27] LONG-TERM EFFICACY OF GUSELKUMAB IN FATIGUE AND IDENTIFICATION OF EARLY TREATMENT TARGETS: POST HOC ANALYSIS THROUGH 2 YEARS OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY CONDUCTED IN BIOLOGIC-NAIVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
Gladman, D. D.
Starr, M.
Ranza, R.
Bravo Perdomo, A. M.
Strauss, M.
Shawi, M.
Han, C.
Rampakakis, E.
Ostor, A. Andrew
Mease, P. J.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1765 - 1765
[28] Long-term Efficacy of Guselkumab in Fatigue and Identification of Early Treatment Targets: Post Hoc Analysis Through 2 Years of a Phase 3, Randomized, Double-blind, Placebo-controlled Study Conducted in Biologic-naive Patients with Active Psoriatic Arthritis
Gladman, Dafna
Starr, Michael
Ranza, Roberto
Perdomo, Ana-Maria Bravo
Strauss, Marcie
Shawi, May
Han, Chenglong
Rampakakis, Emmanouil
Ostor, Andrew
Mease, Philip J.
ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4175 - 4178
[29] Long-term Efficacy of Guselkumab in Fatigue and Identification of Early Treatment Targets: Post Hoc Analysis Through 2 Years of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Conducted in Biologic-Naive Patients With Active Psoriatic Arthritis
Gladman, Dafna
Starr, Michael
Ranza, Roberto
Perdomo, Ana
Strauss, Marcie
Shawi, May
Han, Chenglong
Rampakakis, Emmanouil
Ostor, Andrew
Mease, Philip
JOURNAL OF RHEUMATOLOGY, 2023, 50 (07) : 79 - 79
[30] EFFICACY AND SAFETY OF GUSELKUMAB IN BIOLOGIC-NAIVE PATIENTS WITH ACTIVE AXIAL PSORIATIC ARTHRITIS: STUDY DESIGN OF A PHASE 4, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Gladman, D. D.
Mease, P. J.
Bird, P.
Soriano, E.
Chakravarty, S. D.
Shawi, M.
Xu, S.
Quinn, S.
Gong, C.
Leibowitz, E.
Tam, L. S.
Helliwell, P.
Kavanaugh, A.
Deodhar, A.
Ostergaard, M.
Baraliakos, X.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1574 - 1575

← 1 2 3 4 5 →